Form 8-K - Current report:
SEC Accession No. 0001100682-25-000019
Filing Date
2025-05-07
Accepted
2025-05-07 07:08:39
Documents
15
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crl-20250507.htm   iXBRL 8-K 25310
2 EX-99.1 crl1q25earningsrelease.htm EX-99.1 335517
6 CRL GRAPHIC image_0a.jpg GRAPHIC 47478
  Complete submission text file 0001100682-25-000019.txt   577344

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20250507.xsd EX-101.SCH 1780
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20250507_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20250507_pre.xml EX-101.PRE 12511
17 EXTRACTED XBRL INSTANCE DOCUMENT crl-20250507_htm.xml XML 2729
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 25919255
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)